Amgen stock crashed Tuesday after its weight-loss drug met Wall Street's expectations, but was only on par with Eli Lilly's ...

Amgen's experimental drug MariTide helped overweight or obese patients shed up to 20% of their body weight in a mid-stage ...

Amgen Inc. announced on Tuesday that its experimental weight-loss drug, MariTide, demonstrated an average weight reduction of ...

A highly anticipated obesity-drug candidate from biotech Amgen helped patients shed a significant amount of weight in a ...

The S&P 500 and Nasdaq gained as tech stocks rebounded. Investors analyzed Trump's proposed tariffs, impacting the auto ...

The S&P 500 and Nasdaq Composite rose on Tuesday as investors assessed the threat of new tariffs from President-elect Donald ...

U.S. equities were mixed at midday following comments from President-elect Trump about new tariffs on Chinese, Canadian, and ...

Shares in Amgen fell by double digits Tuesday on long-awaited results for the company’s monthly MariTide shot, which is ...

The 30-stock Dow popped roughly 440 points, or about 1%, to a new record close during regular trading. The S&P 500 gained 0.3 ...

The S&P 500 on Tuesday was trading above its highest close on record with only Fed minutes and the central bank’s preferred inflation gauge in between Wall Street and the Thanksgiving break. The ...

Amgen Inc. shares fell the most in 23 years after its experimental obesity shot failed to significantly outperform rivals and ...

Two Street analysts weigh in on Amgen's phase 2 MariTide data, saying that they would like to see additional details on the ...